Literature DB >> 4074614

The peripheral vascular effects of diltiazem--dose-response characteristics.

M B Finch, G D Johnston.   

Abstract

The acute effects of increasing doses of diltiazem on peripheral blood flow were observed in six subjects. Each subject received, in random order, a single oral dose of placebo or diltiazem 60, 120 or 180 mg. Supine heart rate, blood pressure, skin temperature, digital systolic pressure, forearm and digital blood flow were recorded before and at 1, 2, 3, 4 and 6 h post-dosing. Plasma diltiazem concentrations were measured at each time interval and at 12 and 24 h after the 120 mg dose. At doses of 120 and 180 mg, diltiazem significantly increased digital blood flow at 1, 2, 3, 4 and 6 h post-dosing and forearm blood flow at 2 and 3 h following 180 mg and 3 h following 120 mg. No correlation was observed between plasma diltiazem concentration and changes in peripheral blood flow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074614      PMCID: PMC1400713          DOI: 10.1111/j.1365-2125.1985.tb05095.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  The measurement of volume changes in human limbs.

Authors:  R J WHITNEY
Journal:  J Physiol       Date:  1953-07       Impact factor: 5.182

2.  Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids.

Authors:  V Rovel; M Mitchard; P L Morselli
Journal:  J Chromatogr       Date:  1977-08-11

3.  A random-zero sphygmomanometer.

Authors:  B M Wright; C F Dore
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

4.  Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions.

Authors:  T Nagao; M Sato; H Nakajima; A Kiyomoto
Journal:  Jpn J Pharmacol       Date:  1972-02

5.  Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  O Lederballe Pedersen; C K Christensen; E Mikkelsen; K D Rämsch
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

6.  Assessment of verapamil in the treatment of angina pectoris.

Authors:  F Andreasen; E Boye; E Christoffersen; P Dalsgaard; E Henneberg; A Kallenbach; S Ladefoged; K Lillquist; E Mikkelsen; E Norder0; J Olsen; J K Pedersen; V Pedersen; G B Petersen; J Schroll; H Schultz; J Seidelin
Journal:  Eur J Cardiol       Date:  1975-04

7.  Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.

Authors:  H J Wellens; S L Tan; F W Bär; D R Düren; K I Lie; H M Dohmen
Journal:  Br Heart J       Date:  1977-10

8.  The effects of diltiazem hydrochloride on the cardiac conduction: a clinical study of His bundle electrogram.

Authors:  Y Oyama; Y Imai; H Nakaya; K Kanda; T Satoh
Journal:  Jpn Circ J       Date:  1978-11

9.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

Authors:  E Antman; J Muller; S Goldberg; R MacAlpin; M Rubenfire; B Tabatznik; C S Liang; F Heupler; S Achuff; N Reichek; E Geltman; N Z Kerin; R K Neff; E Braunwald
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

10.  Efficacy of diltiazem for control of symptoms of coronary arterial spasm.

Authors:  S J Rosenthal; R Ginsburg; I H Lamb; D S Baim; J S Schroeder
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

View more
  2 in total

Review 1.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  Diltiazem. A review of its pharmacology and therapeutic use in older patients.

Authors:  A Markham; R N Brogden
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.